Description

ZepSema 70mg Pre-Filled Peptide Pen

60mg Tirzepatide + 10mg Semaglutide Compound

The ZepSema Hybrid Pen combines Tirzepatide and Semaglutide in a convenient pre-filled peptide pen, designed to support appetite control, weight management, and metabolic health. Featuring an easy click-dose system, this formulation eliminates the need for mixing or reconstitution while providing simple and accurate dosing.

By combining two incretin-based compounds, the ZepSema Hybrid Pen may support enhanced satiety, reduced food cravings, improved portion control, and healthy weight-management goals.

Key Benefits:

• Pre-filled and ready to use

• Easy click-dose administration system

• No mixing or reconstitution required

• Helps reduce appetite and food cravings

• Promotes longer-lasting feelings of fullness

• Supports healthy weight-management goals

• Assists with blood sugar management

• May help improve insulin sensitivity

• Supports metabolic health and energy balance

• May be beneficial for individuals with insulin resistance and PCOS

• Convenient once-weekly administration

Research suggests that incretin-based therapies may support weight management and metabolic markers in individuals with PCOS when used under appropriate medical supervision.